GT Biopharma Inc. (GTBP) Announces CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference
GT Biopharma Inc. (GTBP), an immuno-oncology biotechnology company focused on innovative treatments based on the company’s proprietary platforms, announced today the Chief Executive Officer, Dr. Raymond W. Urbanski, will present at the Wedbush PacGrow Healthcare Conference on Wednesday, August 15, at 1:50pm.
Click Here For More Details
Will Canada Produce The Next Green Rush?
A financial boom not seen since the dot-com mania of the late 1990s has taken over Canada. The legalization of recreational marijuana, scheduled for this fall, is not only a momentous social event, but also a rare opportunity for to be in on the birth of what they hope will become a multibillion-dollar industry. One Company has put its wheels in motion & that could mean big potential ahead
Click Here For More Information
Different Ways to Invest in the Booming Cannabis Space
The cannabis market has managed to stay one of the most interesting spaces for financial investment over the past several years, but new updates to the industry continue to bring new opportunity to marijuana. As many states and countries alike begin to legalize the use of cannabis, many companies are working to create new and innovative businesses. These new companies have helped to form a solid base for investors to look at when viewing the marijuana stock market. Over the past few years, several new ways have come to light in terms of how to invest in such a rapidly growing industry.
Disclaimer:Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and Beleave Inc., Midam has been paid $200,000 from the company and ZERO shares of Beleave Inc. for a duration of 6 weeks beginning June 18, 2018 and ending July 31, 2018 NOW EXTENDED TO 8/31/2018. We may buy or sell additional shares of (BLEVF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
